
PharmaCielo
(TSXV) PCLO
PharmaCielo Financials at a Glance
Market Cap
CA$17.86M
Revenue (TTM)
CA$2.61M
Net Income (TTM)
-CA$4.55M
EPS (TTM)
-CA$0.03
P/E Ratio
-3.78
Dividend
CA$0.00
Beta (Volatility)
0.18 (Low)
Dividend
CA$0.00
Beta (Volatility)
0.18 (Low)
Price
CA$0.11
Volume
100,899
Open
CA$0.09
Price
CA$0.11
Volume
100,899
Open
CA$0.09
Previous Close
CA$0.11
Daily Range
CA$0.08 - CA$0.11
52-Week Range
CA$0.04 - CA$0.17
Estimated Earnings Date
Jun 8, 2026
Dividend
CA$0.00
Beta (Volatility)
0.18 (Low)
Price
CA$0.11
Volume
100,899
Open
CA$0.09
Previous Close
CA$0.11
Daily Range
CA$0.08 - CA$0.11
52-Week Range
CA$0.04 - CA$0.17
Estimated Earnings Date
Jun 8, 2026
PCLO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PharmaCielo
Industry
Pharmaceuticals
Sector
Health CareCEO
Marc Lustig, MBA
Website
www.pharmacielo.comHeadquarters
Toronto, ON M5C 1P1, CA
PCLO Financials
Key Financial Metrics (TTM)
Gross Margin
29%
Operating Margin
-1%
Net Income Margin
-2%
Return on Equity
0%
Return on Capital
25%
Return on Assets
-53%
Earnings Yield
-26.46%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
CA$17.86M
Shares Outstanding
187.98M
Volume
100.90K
Avg. Volume
57.64K
Financials (TTM)
Gross Profit
CA$756.41K
Operating Income
-CA$3.82M
EBITDA
-CA$1.00M
Operating Cash Flow
-CA$1.02M
Capital Expenditure
CA$12.00
Free Cash Flow
-CA$1.02M
Cash & ST Invst.
CA$289.24K
Total Debt
CA$18.65M
PharmaCielo Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$606.15K
-46.2%
Gross Profit
CA$1.00M
+107.1%
Gross Margin
1.65%
N/A
Market Cap
CA$17.86M
N/A
Market Cap/Employee
CA$66.64K
N/A
Employees
268
N/A
Net Income
CA$407.41K
+127.1%
EBITDA
CA$869.14K
+305.6%
Quarterly Fundamentals
Net Cash
-CA$18.36M
+9.9%
Accounts Receivable
CA$619.25K
+3.6%
Inventory
CA$1.72M
+14.2%
Long Term Debt
CA$0.00
-100.0%
Short Term Debt
CA$18.65M
+17.7%
Return on Assets
-53.17%
N/A
Return on Invested Capital
24.90%
N/A
Free Cash Flow
CA$530.75K
+235.5%
Operating Cash Flow
CA$530.75K
+235.5%